Foundation

What is liraglutide?

Liraglutide for weight loss

Liraglutide is an FDA-approved prescription medication that may help support chronic weight management in eligible patients when used as part of a medically supervised program that includes nutrition, physical activity, behavior change, and ongoing clinical monitoring.

Although newer weekly medications such as semaglutide and tirzepatide are often considered first, liraglutide may still be an appropriate option for some patients based on medical history, treatment goals, tolerability, access, insurance coverage, and provider recommendation.

Liraglutide quick facts

  • Type: Once-daily GLP-1 injection
  • How it works: Slows gastric emptying so food remains in the stomach longer
  • Main benefit: May help support weight loss and appetite control
  • Used for: Weight management and type 2 diabetes, depending on the patient and prescribing criteria
  • Monitoring: Should be prescribed and followed by a licensed healthcare provider

How liraglutide is taken

Liraglutide was first developed for type 2 diabetes at lower doses and later approved at a higher dose, 3 mg, for chronic weight management under the brand name Saxenda®.

Liraglutide is typically taken as a once-daily subcutaneous injection using a prefilled pen. Treatment usually begins at a low dose and increases gradually over several weeks to help improve tolerability.

Patients should receive clear instruction on injection technique, dosing, storage, missed doses, and follow-up expectations. Regular monitoring helps assess response, side effects, safety, and whether treatment should be continued or adjusted.

Results

Benefits of liraglutide treatment

When prescribed appropriately, liraglutide may offer several potential benefits:

  • Reduced appetite
  • Improved portion control
  • Support for long-term lifestyle change
  • A non-surgical weight loss option
  • Integration with a medically supervised care plan
  • Potential metabolic benefits in qualifying patients

Results vary by patient. Liraglutide should be viewed as one tool within a broader medical weight management strategy, not as a stand-alone treatment.

Eligibility

Who is a candidate for liraglutide?

A medical evaluation is needed to determine whether liraglutide is appropriate. In general, it may be considered for adults who:

  • Have obesity, defined as BMI ≥30 kg/m²
  • Have overweight, defined as BMI ≥27 kg/m², with at least one weight-related condition
  • Have struggled to lose weight through lifestyle changes alone
  • Are willing to participate in an ongoing medical weight loss program
  • Do not have contraindications or safety concerns that would make treatment inappropriate

A provider should review medical history, current medications, weight history, treatment goals, risk factors, and prior response to weight loss therapies before treatment begins.

Calculate My BMI

ft
in
lbs
Mechanism

How is liraglutide different?

Liraglutide is one of several prescription options used in medical weight management. Compared with newer weekly medications, liraglutide requires daily dosing and may differ in tolerability, response, access, insurance coverage, and patient preference.

GLP-1 Treatment Comparison
Liraglutide Semaglutide Tirzepatide
Hormone Pathways GLP-1 GLP-1 GIP + GLP-1
Dosing Frequency Daily Injection Weekly Injection Weekly Injection
Main Effects Appetite Control Appetite Control Appetite + Fat Metabolism
Common Brand Name Saxenda® Wegovy® Zepbound®
FDA Uses Weight Management Diabetes & Weight Loss Diabetes & Obesity
Weight Loss Efficacy Moderate High Higher (clinical studies)
Expected Fat Loss* ~5–10% ~10–15% ~15–20%+

*Results vary. Based on clinical studies when combined with lifestyle changes and medical supervision.

Supervision

Why physician oversight makes the difference

Medical supervision ensures your receive the right treatment for your individual situation. Our physicians monitor your progress closely, adjust your dosing carefully, and guide your nutrition and exercise to optimize results safely. 

Thorough initial assessment

We review your complete medical history, perform a physical exam, and order lab work to ensure semaglutide is appropriate for you.

Personalized dose management

Your physician adjusts your dose based on your individual response and any side effects you may experience.

Ongoing health management

Regular check-ins track your body composition, nutrient levels, and cardiometabolic health throughout the treatment.

FAQs

Find answers to common questions about liraglutide treatment.

Results vary. Some patients notice appetite changes within the first few weeks, while weight loss generally occurs gradually over time. The best results typically occur when medication is combined with nutrition changes, physical activity, behavioral support, and routine follow-up.

Yes. Liraglutide is typically administered as a once-daily subcutaneous injection.

No. Liraglutide, semaglutide, and tirzepatide are different medications. Liraglutide and semaglutide are GLP-1 receptor agonists, while tirzepatide is a dual GIP/GLP-1 receptor agonist.

Liraglutide may support glucose regulation in appropriate patients. Suitability depends on the patient’s medical profile, current medications, and provider assessment.

No. A medical provider should determine whether liraglutide is appropriate based on health history, current conditions, medications, contraindications, treatment goals, and risk factors.

We accept insurance

Find out if we are contracted with your insurance carrier.